Etomidate
Etomidate Injection, USP For intravenous use
Approved
Approval ID
75467058-da52-48fa-8d4e-e1025ec7d461
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 22, 2024
Manufacturers
FDA
Armas Pharmaceuticals Inc.
DUNS: 098405973
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Etomidate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72485-509
Application NumberANDA215028
Product Classification
M
Marketing Category
C73584
G
Generic Name
Etomidate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 22, 2024
FDA Product Classification
INGREDIENTS (3)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
ETOMIDATEActive
Quantity: 2 mg in 1 mL
Code: Z22628B598
Classification: ACTIB
Etomidate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72485-508
Application NumberANDA215028
Product Classification
M
Marketing Category
C73584
G
Generic Name
Etomidate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 22, 2024
FDA Product Classification
INGREDIENTS (3)
ETOMIDATEActive
Quantity: 2 mg in 1 mL
Code: Z22628B598
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT